This is consistent with current evidence demonstrating HMGB1 mediated microglial activation via the HMGB1/TLR4/NFkB axis in several disease contexts, including Parkinson’s disease, stroke, and epilepsy [59,60,61]. Here, NFKB1 is linked to Parkinson disease.